Influenza Vaccination for Cardiovascular Prevention: Further Insights from the IAMI Trial and an Updated Meta-analysis

PURPOSE OF REVIEW: Influenza infection is a significant, well-established cause of cardiovascular disease (CVD) and CV mortality. Influenza vaccination has been shown to reduce major adverse cardiovascular events (MACE) and CV mortality. Therefore, major society guidelines have given a strong recomm...

Descripción completa

Detalles Bibliográficos
Autores principales: Maniar, Yash M., Al-Abdouh, Ahmad, Michos, Erin D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Global Cardiovascular Health (L Sperling and D Gaita, Section Editors)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310360/
https://www.ncbi.nlm.nih.gov/pubmed/35876953
http://dx.doi.org/10.1007/s11886-022-01748-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310360/
https://www.ncbi.nlm.nih.gov/pubmed/35876953
http://dx.doi.org/10.1007/s11886-022-01748-8

Ejemplares similares